Recap: Catalyst Pharmaceuticals Q3 Earnings - Catalyst Pharmaceuticals (NASDAQ:CPRX)

Catalyst Pharmaceuticals CPRX reported its Q3 earnings results on Wednesday, November 8, 2023 at 04:11 PM.

Here's what investors need to know about the announcement.

Catalyst Pharmaceuticals beat estimated earnings by 11.36%, reporting an EPS of $0.49 versus an estimate of $0.44.

Revenue was up $45.44 million from the same period last year.

Last quarter the company beat on EPS by $0.11 which was followed by a 6.37% increase in the share price the next day.

Here's a look at Catalyst Pharmaceuticals's past performance:

Quarter	Q2 2023	Q1 2023	Q4 2022	Q3 2022
EPS Estimate	0.42	0.32	0.21	0.19
EPS Actual	0.53	0.41	0.31	0.26
Revenue Estimate	92.73M	81.62M	58.09M	53.62M
Revenue Actual	99.58M	85.37M	60.76M	57.24M

To track all earnings releases for Catalyst Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.